The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

Sapio Sciences, the science-aware ™ AI lab informatics platform, today announced that the Wellcome Sanger Institute has ...

Scientists pinpoint two cancer genes that when deleted, improve the vulnerability of tumour cells to immunotherapy.

A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers. By looking at multiple layers of ...

The Wellcome Trust Sanger Institute is moving into the post-genomic era with a new five-year £300 million plan. Under the leadership of Allan Bradley, the Institute will concentrate on gene function, ...

Cambridge Innovation Capital plc, a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation of ...

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute Syncona and Cambridge ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

The Wellcome Sanger Institute (WSI), which owns one of Europe’s largest genomic research datacentres, claims to have cut the energy consumption of its server farm by a third by revamping its power ...

The multi-year digital transformation project is led by the Sanger Institute's Core Operations team, which sits at the heart of the Institute. Core Operations provides a broad range of cellular and ...